Galena Biopharma (GALE) Posts Surprise Q4 Profit of 4c/Share
Tweet
Share
E-mailGet Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of $0.04, $0.19 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Galena Biopharma (GALE) click here.
For earnings history and earnings-related data on Galena Biopharma (GALE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
- Jack Henry (JKHY) Tops Q4 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
